Core outcome measures for chronic pain clinical trials: IMMPACT recommendations

Author

DWORKIN, Robert H¹ ; TURK, Dennis C² ; CARR, Daniel B¹⁰ ; CHANDLER, Julie¹¹ ; COWAN, Penney¹² ; DIONNE, Raymond¹³ ; GALER, Bradley S¹⁴ ; HERTZ, Sharon¹⁵ ; JADAD, Alejandro R¹⁶ ; KRAMER, Lynn D¹⁷ ; MANNING, Donald C¹⁸ ; MARTINS, Susan¹⁹ ; FARRAR, John T³ ; MCCORMICK, Cynthia G²⁰ ; MCDERMOTT, Michael P²¹ ; MCGRATH, Patrick²² ; QUESSY, Steve²³ ; RAPPAPORT, Bob A¹⁵ ; ROBBINS, Wendye²⁴ ; ROBINSON, James P² ; ROTHMAN, Margaret²⁵ ; ROYAL, Mike A; SIMON, Lee¹⁵ ; HAYTHORNTHWAITE, Jennifer A⁴ ; STAUFFER, Joseph W; STEIN, Wendy; TOLLETT, Jane; WERNICKE, Joachim; WITTER, James¹⁵ ; JENSEN, Mark P² ; KATZ, Nathaniel P⁵ ; KEMS, Robert D⁶ ; STUCKI, Gerold⁷ ; ALLEN, Robert R⁸ ; BELLAMY, Nicholas⁹
[1] Department of Anesthesiology, University of Rocheser School of Medicine and Dentistry, Rochester, NY 14642, United States
[2] University of Washington, Seattle, WA, United States
[3] University of Pennsylvania, Philaddelphia, PA, United States
[4] Johns Hopkins University, Baltimore, MD, United States
[5] Harvard University, Boston, MA, United States
[6] Yale University, New Haven, CT, United States
[7] University of Munich, Munich, Germany
[8] AstraZeneca, Wilmington, DE, United States
[9] University of Queensland, Brisbane, Qld., Australia
[10] Tufts University, Boston, MA, United States
[11] Merck & Co., Blue Bell, PA, United States
[12] American Chronic Pain Association, Rocklin, CA, United States
[13] National Institute of Dental and Craniofacial Research, Bethesda, MD, United States
[14] Endo Pharmaceuticals Inc., Chadds Ford, PA, United States
[15] Food and Drug Administration, Rockville, MD, United States
[16] University Health Network and University of Toronto, Toronto, Ont., United States
[17] Purdue Pharma, Stamford, CT, United States
[18] Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States
[19] Pfizer Global Research and Development, Ann Arbor, MI, United States
[20] National Institute of Neurological Disorders and Stroke, Bethesda, MD, United States
[21] University of Rochester, Rochester, NY, United States
[22] Dalhousie University, Halifax, NS, Canada
[23] GlaxoSmithKline, Research Triangle Park, NC, United States
[24] NeurogesX, San Carlos, CA, United States
[25] Johnson & Johnson, Raritan, NJ, United States

Source

Pain (Amsterdam). 2005, Vol 113, Num 1-2, pp 9-19, 11 p ; ref : 1 p.3/4

CODEN

PAINDB

ISSN

0304-3959

Scientific domain

Medical oncology; Neurology; Pharmacology drugs; Psychology, psychopathology, psychiatry

Publisher

Elsevier, Amsterdam

Publication country

Netherlands

Document type

Article

Language

English

Author keyword

Adverse events Assessment Chronic pain Clinical trials Emotional functioning Global ratings Health-related quality of lifer Outcomes Physical functioning Randomized controlled trials

Keyword (fr)

Douleur Essai clinique Recommandation

Keyword (en)

Pain Clinical trial Recommendation

Keyword (es)

Dolor Ensayo clínico Recomendación

Classification

Pascal

002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A26 Psychology. Psychophysiology / 002A26N Psychology and medicine / 002A26N03 Illness and personality / 002A26N03B Illness, stress and coping

Francis

770 Psychology. Psychoanalysis. Psychiatry / 770-B Psychology. Psychophysiology

Discipline

Psychology. Ethology

Origin

Inist-CNRS

Database

FRANCIS ; PASCAL

INIST identifier

16416543

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS